On January 20th FDA Watch will drop their first-ever bonus episode of. Join as they take a deep dive into what’s on the horizon with the new-look FDA. More information can be found on FDA Watch’s LinkedIn page, here.
Source: FDAWatch.net | LinkedIn

Permission is granted to reprint or recirculate this column, as long as attribution is made to FDA Matters and the author.
On January 20th FDA Watch will drop their first-ever bonus episode of. Join as they take a deep dive into what’s on the horizon with the new-look FDA. More information can be found on FDA Watch’s LinkedIn page, here.
Source: FDAWatch.net | LinkedIn
FDA Matters provides short-form analysis of FDA policy and regulatory issues. We know you are busy, so we publish 1 to 2 columns per week, each a 3-5 minute read.
FDA Matters does not report the news….we provide analysis of what’s behind the news.
FDA Matters advocates for a more effective, efficient, and fair FDA.

Steven A. Grossman, JD, is the founder and author of FDA Matters. Read more about Steven here.